Benefits
Supports Male Sexual Function
Traditional and preclinical evidence supports use of Cistanche tubulosa phenylethanoid glycosides for sexual vitality in men, with animal models showing improvements in mounting frequency and erectile parameters.
May Support Healthy Testosterone Levels
Animal studies of phenylethanoid glycosides demonstrate upregulation of testicular steroidogenic enzymes (CYP450, 3β-HSD) and increased testosterone synthesis, providing a plausible mechanism for traditional androgenic uses.
Cognitive Support in Older Adults
Echinacoside and acteoside show neuroprotective activity in preclinical models, and a small open-label clinical study in moderate Alzheimer's disease suggested stabilization of cognitive scores over 48 weeks of treatment.
Adaptogenic Vitality Support
Traditional Chinese medicine uses Cistanche for fatigue and reduced vitality, particularly in aging adults. Modern human work pairing Cistanche with Ginkgo has examined chronic-fatigue endpoints with positive direction of effect.
Antioxidant Phenylethanoid Glycosides
Echinacoside and verbascoside are potent radical scavengers in laboratory assays and contribute to anti-inflammatory and neuroprotective activity in cell and animal models.
Mechanism of action
Steroidogenic Enzyme Upregulation
Phenylethanoid glycosides modulate testicular CYP450 and 3β-HSD enzymes, supporting cholesterol-to-testosterone conversion in preclinical models of reproductive dysfunction.
Neuroprotection by Echinacoside
Echinacoside inhibits oxidative stress, supports mitochondrial function, modulates BDNF expression, and attenuates amyloid-β toxicity in cell and animal models of neurodegeneration.
Cholinergic Modulation
Cistanche extracts reverse cholinergic dysfunction and partially restore hippocampal dopaminergic transmission in Alzheimer's-like rodent models, contributing to the cognitive signal.
Anti-Inflammatory and Antioxidant
Phenylethanoid glycosides scavenge ROS, inhibit NF-κB activation, and reduce pro-inflammatory cytokines in vitro, supporting broader effects on age-related tissue stress.
Clinical trials
Open-label, non-placebo-controlled study of standardized Cistanche tubulosa glycoside capsules (Memoregain®) over 48 weeks. Outcomes: ADAS-cog, MMSE, ADL, Blessed Behavioral Scale, CGI.
18 patients with moderate Alzheimer's disease; 48-week intervention.
ADAS-cog scores improved in 10, deteriorated in 7, and stayed unchanged in 1 patient over 48 weeks. MMSE and ADL scores remained stable; adverse events were mild. Suggests Memoregain® may help support cognitive stability in moderate AD, though the open-label design limits causal interpretation.
Randomized, double-blind, placebo-controlled trial of a botanical formulation combining Cistanche tubulosa and Ginkgo biloba extracts in adults aged 35-60 with chronic-fatigue-syndrome-like symptoms.
Adults aged 35-60 with chronic fatigue symptoms.
The combined botanical product was associated with improvements in fatigue and vitality measures vs placebo. Cistanche's contribution cannot be isolated from Ginkgo, but the combination signal is consistent with traditional adaptogenic positioning.